Life ScienceCompany
Melinta Therapeutics M&A Summary
Melinta Therapeutics has acquired 1 company. It has also divested 1 asset.
Melinta Therapeutics’ largest acquisition to date was in 2017, when it acquired The Medicines Company - Infectious Disease Business for $270M. Melinta Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Melinta Therapeutics Business Overview
Where is Melinta Therapeutics headquartered?
Melinta Therapeutics is headquartered in New Haven, Connecticut.
What sector is Melinta Therapeutics in?
Melinta Therapeutics is a life science company.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 2
- M&A Advisors 1